Age Alone Should Not Dictate Myeloma Treatment
A real-world study of 561 patients aged 65–75 finds that autologous stem cell transplantation and quadruplet therapy improve progression-free survival, ...
A real-world study of 561 patients aged 65–75 finds that autologous stem cell transplantation and quadruplet therapy improve progression-free survival, ...
A multicenter randomized trial demonstrates that remimazolam matches midazolam in dental sedation success while accelerating recovery and reducing next-day adverse ...
A systematic review of 18 studies, with 12 contributing to quantitative synthesis, does not establish a consistent survival advantage for ...
A phase III trial in China found that dose-dense nab-paclitaxel significantly improved residual cancer burden rates compared to docetaxel in ...
A multicenter randomized trial evaluating adjunctive intra-arterial tenecteplase following successful thrombectomy for acute basilar artery occlusion was terminated early due ...
A single-center cohort study finds that baseline high disease activity does not significantly predict short-term response to efgartigimod in patients ...
A large international trial shows that combining immunotherapy and a targeted drug before surgery reduces the risk of death by ...
A prospective multicenter clinical trial found that the Jetstream Atherectomy System achieved high technical success and low complication rates in ...
A secondary analysis of the TOPCAT trial found spironolactone associated with lower death and hospitalization risks in frail HFpEF patients, ...
A meta-analysis of 753 patients shows rituximab remission rates vary significantly by kidney pathology and prior treatment response, supporting precision-based ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine